Tag: MacroGenics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to MacroGenics

MacroGenics (NASDAQ:MGNX) Earns Buy Rating from HC Wainwright

Added to Collection on: 2019-05-25 19:48:45

Tags for this article:

Finance
Financial markets
Financial economics
Stock market
Corporate finance
Stock
Price?earnings ratio
Short
BlackRock
MacroGenics

Click the tags to see associated articles and topics

View Article Details
MacroGenics wins FDA approval of breast cancer drug

Added to Collection on: 2020-12-17 16:30:00

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Immunology
Breast cancer
Trastuzumab
HER2/neu
Margetuximab
Breast cancer management
Metastatic breast cancer
Treatment of cancer
Trastuzumab emtansine
Roche
MacroGenics

Click the tags to see associated articles and topics

View Article Details
MacroGenics HER2 drug scores FDA breast cancer nod with Herceptin-topping data

Added to Collection on: 2020-12-17 16:30:00

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Immunology
Antineoplastic drugs
Breast cancer
Trastuzumab
Margetuximab
HER2/neu
Antibody-drug conjugate
Metastatic breast cancer
Trastuzumab emtansine
MacroGenics

Click the tags to see associated articles and topics

View Article Details
MacroGenics' HER2 breast cancer drug Margenza approved in US

Added to Collection on: 2020-12-18 11:03:45

Tags for this article:

Clinical medicine
Drugs
Medicine
Antineoplastic drugs
Cancer treatments
Breakthrough therapy
Orphan drugs
Immunology
Trastuzumab
HER2/neu
Trastuzumab emtansine
Tucatinib
Roche
MacroGenics

Click the tags to see associated articles and topics

View Article Details
MacroGenics Adopts Genedata Profiler to Enhance Development of Immunotherapies

Added to Collection on: 2021-04-19 12:22:30

Tags for this article:

Health sciences
Genedata
Health
Workflow
Clinical trial
Bioinformatics
Articles
Switzerland
MacroGenics

Click the tags to see associated articles and topics

View Article Details
Gilead, MacroGenics Unite Against Hematologic Cancers in $1.7B Biobuck Deal

Added to Collection on: 2022-10-17 20:05:32

Tags for this article:

Medical specialties
Monoclonal antibodies
Immunology
Life Sciences
Immune system
Biotechnology
Enoblituzumab
Gilead Sciences
Bispecific monoclonal antibody
Cancer immunotherapy
MacroGenics

Click the tags to see associated articles and topics

View Article Details